ASPIRING (Antiplatelet Secondary Prevention International Randomised trial after IN tracerebral haemorrhage) is an investigator-led, multicentre, prospective, randomised, open-label, blinded outcome (PROBE), parallel-group clinical trial which aims..
Relevance: 9.315439